Andre Pereira Fraga Figueiredo
Directeur/Membre du Conseil chez GENETETHER THERAPEUTICS INC.
Fortune : 64 077 $ au 31/05/2024
Profil
Mr. Andre Pereira Fraga Figueiredo is a General Manager at Aurea Holdings LLC and an Independent Director at GeneTether Therapeutics, Inc. He is on the Board of Directors at GeneTether Therapeutics, Inc. and GeneTether, Inc. He received his undergraduate degree from Portuguese Catholic University and an MBA from the Instituto de Empresa SL.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 07/03/2023 | 2 563 061 ( 6,63% ) | 64 077 $ | 31/05/2024 |
Postes actifs de Andre Pereira Fraga Figueiredo
| Sociétés | Poste | Début |
|---|---|---|
| GENETETHER THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/01/2021 |
GeneTether, Inc.
 GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Directeur/Membre du Conseil | - |
| Aurea Holdings LLC | Fondateur | 01/01/2021 |
Formation de Andre Pereira Fraga Figueiredo
| Instituto de Empresa SL | Masters Business Admin |
| Portuguese Catholic University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENETETHER THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Commercial Services |
| Aurea Holdings LLC |
